Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease
Open Access
- 14 February 1997
- journal article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 223 (1), 29-32
- https://doi.org/10.1016/s0304-3940(97)13394-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Characterization of the Binding of Amyloid‐β Peptide to Cell Culture‐Derived Native Apolipoprotein E2, E3, and E4 Isoforms and to Isoforms from Human PlasmaJournal of Neurochemistry, 1997
- ApoE genotypes in AustraliaNeuroReport, 1995
- Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseNature, 1995
- Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's diseaseNature Genetics, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndromeAnnals of Neurology, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984